953 |
Trial of Endovascular Thrombectomy for Large Ischemic Strokes
|
2023-04-26 |
331 |
952 |
Admission systolic blood pressure and effect of endovascular treatment in patients with ischaemic stroke: an individual patie
|
2023-04-26 |
288 |
951 |
Plasma Inflammatory Biomarkers Are Associated With Poststroke Cognitive Impairment: The Nor-COAST Study
|
2023-04-26 |
263 |
950 |
Dissociable Contributions of Thalamic-Subregions to Cognitive Impairment in Small Vessel Disease
|
2023-03-30 |
319 |
949 |
Association Between Magnitude of Differential Blood Pressure Reduction and Secondary Stroke Prevention: A Meta-analysis and M
|
2023-03-30 |
295 |
948 |
Ticagrelor Aspirin vs Clopidogrel Aspirin in CYP2C19 Loss-of-Function Carriers With Minor Stroke or TIA Stratified by Risk Pr
|
2023-03-30 |
321 |
947 |
A Genomic Risk Score Identifies Individuals at High Risk for Intracerebral Hemorrhage
|
2023-02-27 |
354 |
946 |
Stroke Lesion Volume and Injury to Motor Cortex Output Determines Extent of Contralesional Motor Cortex Reorganization
|
2023-02-27 |
307 |
945 |
Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial
|
2023-02-27 |
438 |
944 |
Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke
|
2023-01-31 |
376 |
943 |
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|
2023-01-31 |
322 |
942 |
Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AF
|
2023-01-31 |
320 |
941 |
One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventr
|
2022-12-29 |
390 |
940 |
Association of Noncontrast Computed Tomography and Perfusion Modalities With Outcomes in Patients Undergoing Late-Window Stro
|
2022-12-29 |
364 |
939 |
Association of Endovascular Thrombectomy vs Medical Management With Functional and Safety Outcomes in Patients Treated Beyond
|
2022-12-29 |
377 |